These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32767816)

  • 41. IQGAP1 is an oncogenic target in canine melanoma.
    Lee BH; Neela PH; Kent MS; Zehnder AM
    PLoS One; 2017; 12(4):e0176370. PubMed ID: 28445541
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation and Design of Genome-Wide CRISPR/SpCas9 Knockout Screens.
    Hart T; Tong AHY; Chan K; Van Leeuwen J; Seetharaman A; Aregger M; Chandrashekhar M; Hustedt N; Seth S; Noonan A; Habsid A; Sizova O; Nedyalkova L; Climie R; Tworzyanski L; Lawson K; Sartori MA; Alibeh S; Tieu D; Masud S; Mero P; Weiss A; Brown KR; Usaj M; Billmann M; Rahman M; Constanzo M; Myers CL; Andrews BJ; Boone C; Durocher D; Moffat J
    G3 (Bethesda); 2017 Aug; 7(8):2719-2727. PubMed ID: 28655737
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of dual-specificity phosphatase 26 by ethyl-3,4-dephostatin: Ethyl-3,4-dephostatin as a multiphosphatase inhibitor.
    Seo H; Cho S
    Pharmazie; 2016 Apr; 71(4):196-200. PubMed ID: 27209699
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pooled Lentiviral CRISPR-Cas9 Screens for Functional Genomics in Mammalian Cells.
    Aregger M; Chandrashekhar M; Tong AHY; Chan K; Moffat J
    Methods Mol Biol; 2019; 1869():169-188. PubMed ID: 30324523
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High-Resolution CRISPR Screens Reveal Fitness Genes and Genotype-Specific Cancer Liabilities.
    Hart T; Chandrashekhar M; Aregger M; Steinhart Z; Brown KR; MacLeod G; Mis M; Zimmermann M; Fradet-Turcotte A; Sun S; Mero P; Dirks P; Sidhu S; Roth FP; Rissland OS; Durocher D; Angers S; Moffat J
    Cell; 2015 Dec; 163(6):1515-26. PubMed ID: 26627737
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genome wide-scale CRISPR-Cas9 knockout screens identify a fitness score for optimized risk stratification in colorectal cancer.
    Yang X; Liu J; Wang S; Al-Ameer WHA; Ji J; Cao J; Dhaen HMS; Lin Y; Zhou Y; Zheng C
    J Transl Med; 2024 Jun; 22(1):554. PubMed ID: 38858785
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dual specificity phosphatase (DUSP)-4 is induced by platelet-derived growth factor -BB in an Erk1/2-, STAT3- and p53-dependent manner.
    Yin R; Eger G; Sarri N; Rorsman C; Heldin CH; Lennartsson J
    Biochem Biophys Res Commun; 2019 Nov; 519(3):469-474. PubMed ID: 31526568
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dual specificity phosphatases 10 and 16 are positive regulators of EGF-stimulated ERK activity: indirect regulation of ERK signals by JNK/p38 selective MAPK phosphatases.
    Finch AR; Caunt CJ; Perrett RM; Tsaneva-Atanasova K; McArdle CA
    Cell Signal; 2012 May; 24(5):1002-11. PubMed ID: 22245064
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Upregulation of DUSP6 impairs infectious bronchitis virus replication by negatively regulating ERK pathway and promoting apoptosis.
    Wang H; Liu D; Sun Y; Meng C; Tan L; Song C; Qiu X; Liu W; Ding C; Ying L
    Vet Res; 2021 Jan; 52(1):7. PubMed ID: 33431056
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Knockdown of dual specificity phosphatase 4 enhances the chemosensitivity of MCF-7 and MCF-7/ADR breast cancer cells to doxorubicin.
    Liu Y; Du F; Chen W; Yao M; Lv K; Fu P
    Exp Cell Res; 2013 Dec; 319(20):3140-9. PubMed ID: 24012960
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dynamic reprogramming of signaling upon met inhibition reveals a mechanism of drug resistance in gastric cancer.
    Lai AZ; Cory S; Zhao H; Gigoux M; Monast A; Guiot MC; Huang S; Tofigh A; Thompson C; Naujokas M; Marcus VA; Bertos N; Sehat B; Perera RM; Bell ES; Page BD; Gunning PT; Ferri LE; Hallett M; Park M
    Sci Signal; 2014 Apr; 7(322):ra38. PubMed ID: 24757178
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impaired Dual-Specificity Protein Phosphatase DUSP4 Reduces Corticosteroid Sensitivity.
    Kobayashi Y; Ito K; Kanda A; Tomoda K; Mercado N; Barnes PJ
    Mol Pharmacol; 2017 May; 91(5):475-481. PubMed ID: 28283554
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dual specificity phosphatase 9 (DUSP9) expression is down-regulated in the severe pre-eclamptic placenta.
    Czikk MJ; Drewlo S; Baczyk D; Adamson SL; Kingdom J
    Placenta; 2013 Feb; 34(2):174-81. PubMed ID: 23276385
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dual specificity phosphatase 4 mediates cardiomyopathy caused by lamin A/C (LMNA) gene mutation.
    Choi JC; Wu W; Muchir A; Iwata S; Homma S; Worman HJ
    J Biol Chem; 2012 Nov; 287(48):40513-24. PubMed ID: 23048029
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The microRNA-429/DUSP4 axis regulates the sensitivity of colorectal cancer cells to nintedanib.
    Cheng G; Li Y; Liu Z; Song X
    Mol Med Rep; 2021 Apr; 23(4):. PubMed ID: 33495832
    [TBL] [Abstract][Full Text] [Related]  

  • 56. miR‑122‑5p suppresses the oncogenesis of PTC by inhibiting DUSP4 expression.
    Hu N; Tian Y; Song Y; Zang L
    Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760201
    [TBL] [Abstract][Full Text] [Related]  

  • 57. DUSP 4 expression identifies a subset of colorectal cancer tumors that differ in MAPK activation, regardless of the genotype.
    De Vriendt V; De Roock W; Di Narzo AF; Tian S; Biesmans B; Jacobs B; Budinska E; Sagaert X; Rossi S; D'Ario G; Delorenzi M; Simon I; Vecchione L; Tejpar S
    Biomarkers; 2013 Sep; 18(6):516-24. PubMed ID: 23875912
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lysine-Specific Histone Demethylase 1 Promotes Oncogenesis of the Esophageal Squamous Cell Carcinoma by Upregulating DUSP4.
    Han J; Ye S; Chen J; Wang K; Jin J; Zeng Z; Xue S
    Biochemistry (Mosc); 2021 Dec; 86(12):1624-1634. PubMed ID: 34937541
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CRISPR Screens Provide a Comprehensive Assessment of Cancer Vulnerabilities but Generate False-Positive Hits for Highly Amplified Genomic Regions.
    Munoz DM; Cassiani PJ; Li L; Billy E; Korn JM; Jones MD; Golji J; Ruddy DA; Yu K; McAllister G; DeWeck A; Abramowski D; Wan J; Shirley MD; Neshat SY; Rakiec D; de Beaumont R; Weber O; Kauffmann A; McDonald ER; Keen N; Hofmann F; Sellers WR; Schmelzle T; Stegmeier F; Schlabach MR
    Cancer Discov; 2016 Aug; 6(8):900-13. PubMed ID: 27260157
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CRISPR-Cas9 Screening of Kaposi's Sarcoma-Associated Herpesvirus-Transformed Cells Identifies XPO1 as a Vulnerable Target of Cancer Cells.
    Gruffaz M; Yuan H; Meng W; Liu H; Bae S; Kim JS; Lu C; Huang Y; Gao SJ
    mBio; 2019 May; 10(3):. PubMed ID: 31088931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.